 |
For many years, CSRO has worked with the State Access to Innovative Medicines (SAIM) Coalition, which is the primary organizing vehicle for patient and provider advocacy organizations on the issues of step therapy and standard benefit design reform in the states. Expanding on this longtime partnership, CSRO is helping lead a new prior authorization workgroup within SAIM.
To better understand the challenges prior authorization puts on practices and their patients, this workgroup has developed a detailed survey to gather insights from healthcare providers.
Your feedback will help us better understand the impact of prior authorization on patient care, identify the most burdensome aspects, and explore potential solutions to improve the process. This information will then be used to inform policy recommendations and advocacy work to create more efficient and patient-centered prior authorization practices.
Thank you for your feedback.
Please feel free to encourage participation from other healthcare providers by sharing this link with your network.
